The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers.  The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com
 

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Taiho Oncology, Inc.

Tim Whitten

Volker Wacheck

Tuyen D.

Tehseen Salimi

Sushil Rijhwani

Sarita T.

Said P. Rahal

Robert Chernitsky

Ravi Sharan PMP PgMP

Ratan Ratnesh

Nick Carroll

Muriel Granier

Michael Schick

Masayuki Kanai

Kazuhiko Okamoto, CPA

Kathy Calarco

Jun Edo Orlanes, MBA, DBA, LSSMBB, ASQ, GxP, ISO, PMP

Juliet Agranoff, MS

Helen He

Peter Foertig, MD

Elizabeth Calleja

Ed Chapman

Christine Guertin

Abdel Halim, PharmD, MSc, PhD, DABCC, FAACC

The Leadership Team at Taiho Oncology, Inc. is responsible for strategic decision-making and guiding the overall direction of the company. This diverse group oversees key areas including clinical development, regulatory affairs, marketing, and business operations, ensuring that innovative anti-cancer therapies are effectively developed and delivered to patients. By collaborating across departments, the Leadership Team drives initiatives that align with Taiho's mission to improve the lives of cancer patients and their caregivers.

Leadership Team

Clinical Operations Team

Leadership Team

About

Team members

Other teams at Taiho Oncology, Inc.

Clinical Operations Team

Leadership Team